Historical Stock Price
EIGR historical stock prices picture
EIGR (EIGR) has the following price history information. Looking back at EIGR historical stock prices for the last five trading days, on April 04, 2024, EIGR opened at $1.85, traded as high as $2.88 and as low as $1.75, and closed at $2.26. Trading volume was a total of 1.31M shares. On April 05, 2024, EIGR opened at $2.40, traded as high as $2.60 and as low as $1.86, and closed at $2.30. Trading volume was a total of 311.40K shares. On April 08, 2024, EIGR opened at $2.21, traded as high as $2.24 and as low as $2.00, and closed at $2.11. Trading volume was a total of 129.80K shares. On April 09, 2024, EIGR opened at $2.02, traded as high as $2.10 and as low as $1.88, and closed at $1.90. Trading volume was a total of 117.70K shares. On April 10, 2024, EIGR opened at $1.90, traded as high as $1.90 and as low as $1.66, and closed at $1.73. Trading volume was a total of 131.60K shares.

EIGR Historical Stock Prices By Date:

EIGR historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into EIGR shares, starting with a $10,000 purchase of EIGR, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/29/2014
End date: 04/10/2024
Start price/share: $5,287.50
End price/share: $1.73
Dividends collected/share: $0.00
Total return: -99.97%
Average Annual Total Return: -55.35%
Starting investment: $10,000.00
Ending investment: $3.26
Years: 9.96
Date Open High Low Close Volume
04/04/2024 $1.85 $2.88 $1.75 $2.26 1.31M
04/05/2024 $2.40 $2.60 $1.86 $2.30 311.40K
04/08/2024 $2.21 $2.24 $2.00 $2.11 129.80K
04/09/2024 $2.02 $2.10 $1.88 $1.90 117.70K
04/10/2024 $1.90 $1.90 $1.66 $1.73 131.60K
Eiger BioPharmaceuticals is a commercial-stage biopharmaceutical company. Co.'s portfolio includes a late-stage clinical development pipeline with five clinical product candidates and one U.S. Food and Drug Administration (FDA)-approved product. Co.'s clinical product candidates include: Lonafarnib for Hepatitis Delta Virus (HDV), Peginterferon Lambda for HDV, Combination Therapy for HDV; Peginterferon Lambda (lambda) for COVID-19, Avexitide in Congenital Hyperinsulinism, and Avexitide in Post-Bariatric Hypoglycemia. Co. has received FDA approval for Zokinvy to reduce the risk of mortality in Progeria and to treat processing-deficient Progeroid Laminopathies.
Date Close
04/04/2024$2.26
04/05/2024$2.30
04/08/2024$2.11
04/09/2024$1.90
04/10/2024$1.73
EIGR is categorized under the Healthcare sector; below are some other companies in the same sector:

EKG Historical Stock Prices
EKO Historical Stock Prices
EKSO Historical Stock Prices
ELGX Historical Stock Prices
ELMD Historical Stock Prices
ELOS Historical Stock Prices
EMS Historical Stock Prices
ENDP Historical Stock Prices
ENMD Historical Stock Prices
ENSG Historical Stock Prices

Also explore: EIGR shares outstanding history

Email EnvelopeFree EIGR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


EIGR Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.